As of November 2024 Immunovant has a market cap of A$6.05 Billion. This makes Immunovant the world's 3123th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 15th, 2024 the market cap of Immunovant was reported to be: